Phio Pharmaceuticals Corp (PHIO)
0.6919
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
0.6919
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Operations (Quarterly): -2.011M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.011M |
| December 31, 2023 | -2.37M |
| September 30, 2023 | -2.90M |
| June 30, 2023 | -2.771M |
| March 31, 2023 | -2.708M |
| December 31, 2022 | -2.705M |
| September 30, 2022 | -3.526M |
| June 30, 2022 | -2.429M |
| March 31, 2022 | -3.469M |
| December 31, 2021 | -2.471M |
| September 30, 2021 | -2.866M |
| June 30, 2021 | -3.255M |
| March 31, 2021 | -3.266M |
| December 31, 2020 | -2.623M |
| September 30, 2020 | -1.971M |
| June 30, 2020 | -2.032M |
| March 31, 2020 | -2.176M |
| December 31, 2019 | -2.546M |
| September 30, 2019 | -1.991M |
| June 30, 2019 | -1.933M |
| March 31, 2019 | -2.175M |
| December 31, 2018 | -1.746M |
| September 30, 2018 | -2.007M |
| June 30, 2018 | -1.86M |
| March 31, 2018 | -1.907M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.201M |
| September 30, 2017 | -2.197M |
| June 30, 2017 | -2.317M |
| March 31, 2017 | -2.799M |
| December 31, 2016 | -1.372M |
| September 30, 2016 | -1.603M |
| June 30, 2016 | -1.86M |
| March 31, 2016 | -2.925M |
| December 31, 2015 | -1.582M |
| September 30, 2015 | -1.963M |
| June 30, 2015 | -1.80M |
| March 31, 2015 | -1.972M |
| December 31, 2014 | -1.595M |
| September 30, 2014 | -1.766M |
| June 30, 2014 | -2.017M |
| March 31, 2014 | -2.38M |
| December 31, 2013 | -1.402M |
| September 30, 2013 | -1.725M |
| June 30, 2013 | -2.056M |
| March 31, 2013 | -1.128M |
| December 31, 2012 | -1.15M |
| September 30, 2012 | -1.257M |
| June 30, 2012 | -1.446M |
| March 31, 2012 | -1.209M |
| December 31, 2011 | -2.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.526M
Minimum
Sep 2022
-1.933M
Maximum
Jun 2019
-2.601M
Average
-2.584M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.004M |
| Free Cash Flow | -10.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4391 |
| Free Cash Flow Yield | -494.2% |